Solutions
Online Inquiry
Global Services. (Creative Biolabs Authorized)

KIR CAR Construction Service

Online Inquiry
Service Background What We Can Offer Workflow Highlights FAQs Related Services Contact

KIR-based CAR design is a pioneering approach in the field of CAR-T therapy. It involves the incorporation of Killer-cell Immunoglobulin-like Receptors (KIRs) into the CAR construct. KIRs are a family of cell surface proteins found on natural killer (NK) cells and a subset of T cells. These receptors play a pivotal role in regulating the immune response by interacting with Human Leukocyte Antigens (HLAs) on the surface of target cells.

By integrating KIRs into CAR-T cells, our KIR-based CAR design service at Creative Biolabs aims to enhance the specificity, efficacy, and safety of CAR-T therapy. This innovative approach provides a means to fine-tune the immune response and overcome certain limitations of conventional CAR-T therapies, especially in the context of solid tumors and the challenges posed by the tumor microenvironment.

KIR CAR Construction Services

Our expert team of scientists and engineers is proficient in designing, optimizing, and validating KIR-based CAR-T constructs. The key components of our KIR CAR construction services include:

  • KIR Selection and Optimization
    We employ a rigorous process for the selection of KIRs based on their compatibility with the target tumor and their immunomodulatory properties. Through advanced bioinformatics and molecular modeling, we optimize the KIR component for maximal binding affinity and functionality.
  • KIR CAR Design and Construction
    Our CAR vector design is characterized by precision and efficiency. We incorporate the KIR segment seamlessly into the CAR construct, ensuring proper co-expression with other CAR components. The design of the CAR vector is tailored to the specific requirements of the therapy.
  • KIR CAR Validation
    Before advancing to clinical trials, our KIR CAR constructs undergo rigorous in vitro and in vivo validation. This step is critical to assess the functionality, safety, and efficacy of the KIR-based CAR-T cells.
  • Customization and Scale-Up
    We understand that each therapeutic application is unique. Therefore, we offer customizable KIR CAR construction services, allowing for the fine-tuning of CAR-T cells to target different tumor types or to address specific patient needs. Our capabilities extend to scalable production for clinical trials and commercial applications.

Advantages of KIR CAR-T

A CAR constructed using this natural multi-chain immunoreceptor design offers several compelling reasons for showing sustained efficacy in CAR-T resistant tumor models, ultimately leading to complete tumor remission:

  • Prolongs T Cell Function: This design allows T cells to maintain their functionality over an extended period, ensuring a sustained immune response against the tumor.
  • Bypasses CD3ζ Co-Stimulation: The activation pathway in the DAP12 molecule enables T cells to activate without the need for CD3ζ co-stimulation. This unique feature enhances the CAR's effectiveness in the face of resistance.
  • Prevents T Cell Exhaustion: KIR-CAR T cells can be activated by coupling the receptor chains, and they can rest by decoupling them. This dynamic regulation helps prevent T cell exhaustion, ensuring their long-term activity against the tumor.
  • Stable Expression on T Cell Surfaces: KIR CARs express on both activated and non-activated T cell surfaces consistently. This stability signifies their superior anti-tumor function, especially in the challenging microenvironments of solid tumors.

Please contact us to advance the success of your research.

What We Can Offer

Creative Biolabs utilizes a state-of-the-art, non-infringing technology stack covering the entire KIR-CAR development process, from initial gene design through final functional validation, ensuring a high-quality, translational product.

Vector Construction and Synthesis Platforms Cellular and Functional Validation Platforms
  • Advanced Gene Synthesis & Cloning
  • Viral Vector Manufacturing
  • Genetic Optimization Systems
  • High-Dimensional Flow Cytometry
  • Real-Time Cell Analysis
  • High-Sensitivity Cytokine Profiling

This rigorous, validated platform workflow ensures that your KIR-CAR T-cell candidates are built for maximum potency and regulatory compliance.

Detailed Project Workflow

Workflow of KIR CAR construction service. (Creative Biolabs Original)

Unique Features

  • Advanced Cell Product Characterization: Utilization of multi-dimensional Flow Cytometry to provide deep insights into cell purity, phenotype, and stability.
  • Strict Aseptic Verification: Strict aseptic verification procedures and a high-standard quality control system are maintained throughout the process, ensuring product integrity and safety.
  • Guaranteed Performance: Creative Biolabs guarantees specified transduction efficiencies and provides full batch-to-batch consistency reports, securing the reliability of your therapeutic candidate.

Connect with us today to obtain detailed details and tailor-make your service package.

FAQs

What makes KIR-based CARs different from conventional CAR designs?

KIR CARs leverage KIR signaling domains, which can offer stronger persistence, balanced activation, and reduced exhaustion compared to traditional CAR formats. This makes them especially attractive for enhancing NK- or T-cell–based therapies.

Can I use KIR CARs for both T cells and NK cells?

Yes. While KIR domains are naturally associated with NK cell biology, they can also be integrated into CAR-T designs to provide alternative signaling pathways. We help you adapt the KIR CAR architecture to the effector cell type that best fits your project goals.

How do KIR CARs compare to second and third-generation CARs?

Traditional CAR generations typically rely on CD28 or 4-1BB co-stimulatory domains. KIR CARs represent an alternative signaling pathway that may complement or outperform these depending on the therapeutic context. We help you evaluate whether a KIR-based design is more suitable for your target disease compared to conventional CAR formats.

Related Services

Chemically Programmed Switch CAR Construction

We construct chemically programmed switch CARs offering external drug control. Our services include design, engineering, and validation, addressing safety concerns, reducing uncontrolled activity, and providing precise therapeutic regulation.

CD3ε-based CAR Design & Construction

Our team designs CD3ε-based CARs utilizing natural TCR signaling pathways. Services include vector engineering and validation, addressing weak CAR activation and enhancing signal strength for improved antitumor responses.

Adnectin-based CAR Design & Construction

Creative Biolabs engineers adnectin-based CARs as antibody alternatives. Our services include scaffold design, optimization, and testing, addressing limitations of scFvs and providing stable, versatile targeting options for innovative cellular therapies.

Why Choose Us?

Creative Biolabs is your trusted partner for engineering the next generation of adoptive cell therapies. Our KIR CAR construction service provides the critical engineering, quality control, and functional validation required to transform complex scientific concepts into high-impact clinical candidates. Ready to advance your immuno-oncology program with superior cell engineering? Inquire now to receive detailed specifications and customize your service package.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Key Updates
Newsletter. (Creative Biolabs Authorized) NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution. (Creative Biolabs Authorized) NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
Novel Solution. (Creative Biolabs Authorized) NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
New Technology. (Creative Biolabs Authorized) NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.